Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PAxlovid loNg cOvid-19 pRevention triAl With recruitMent In the Community in Norway

NCT05852873 is registered in ClinicalTrials.gov with Haukeland University Hospital as lead sponsor.

NCT NCT05852873
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05852873 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PAxlovid loNg cOvid-19 pRevention triAl With recruitMent In the Community in Norway
Lead sponsor
Haukeland University Hospital
Phase
Phase 3
Overall status
Active, not recruiting
Start date
May 12, 2023
Completion date
June 11, 2027
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, post covid-19 condition, unspecified, sars-cov2 infection